|
PHARMACY-PHARMACEUTICS Course Descriptions |
MSB 100 |
392-3223 |
|---|
UNDERGRADUATE ADVISER(S): M. MCKENZIE, J. HUGHES
|
GRADUATE ADVISER: G. HOCHHAUS, L. PROKAI
|
| DEPT-CRSE |
CF |
CC | GE |
REQ | SECT |
CRED | -DAY(S)- |
PERIOD | BLDG |
ROOM | EXAM |
COURSE-TITLE-OF-SECTION |
INSTRUCTOR |
|
PHA 4905 |
| |
| X | 7188X |
VAR | TBA | |
| | FE |
PROB IN PHARMACEUTICS | HUGHES |
| PHA 5101 | | |
| X | 7189X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | DIMOVA |
| PHA 5101 | | |
| X | 7190X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | NGUYEN |
| PHA 5101 | | |
| X | 7191X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | GONG |
| PHA 5101 | | |
| X | 7192X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | TANG |
| PHA 5101 | | |
| X | 7193X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | DIMOVA |
| PHA 5101 | | |
| X | 7194X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | NGUYEN |
| PHA 5101 | | |
| X | 7195X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | GONG |
| PHA 5101 | | |
| X | 7196X |
02 | TBA | |
| | FE |
DOSAGE FORMS 2 | TANG |
| PHA 5128 | | |
| X | 7197X |
02 | TBA | |
| | FE |
DOSE OPTIMIZATION 2 | DERENDORF |
|
PHA 5655 |
| |
| X | DEP-X |
04 | TBA | |
| | NFE |
CLERKSHIP RESEARCH | DERENDORF |
|
PHA 5905 |
| |
| X | DEP-X |
02 | TBA | |
| | NFE |
CLIN PHARM RESEARCH | PROKAI |
| PHA 5933 | | |
| X | 1214X |
02 | T R | 4-5 |
| | FE |
SELECT TOP PHARMACY | HUGHES |
|
PHA 6118 |
| |
| X | DEP-X |
02 | TBA | |
| | NFE |
MOLECULAR DIVERSITY | PROKAI |
|
PHA 6125 |
| |
| X | 3278X |
03 | TBA | |
| | NFE |
PHARMACOKN & BIOPHARM | DERENDORF |
|
PHA 6170C |
| |
| Z | 3622Z |
03 | TBA | |
| | NFE |
PHARMACEU PROD FORM | BRAZEAU |
|
PHA 6440 |
| |
| X | 7208X |
01 | TBA | |
| | FE |
SEMINAR DRUG DISCOVER | PROKAI |
|
PHA 6938 |
| |
| X | 7210X |
01 | TBA | |
| | FE |
RESEARCH SEMINAR | HUGHES |
|
PHA 7979 |
| |
| X | 7221X |
VAR | TBA | |
| | FE |
ADVANCED RESEARCH | HOCHHAUS |
|
PHA 7980 |
| |
| X | 7222X |
VAR | TBA | |
| | FE |
DOCTORAL RESEARCH | DERENDORF |